Self- and family management program
Self- and family management program has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Mar 19, 2026: “Health outcomes of self- and family management programs among community-dwelling older people with chronic obstructive pulmonary disease: a randomized controlled trial”.
1 paper studies it8 findingsUpdated
See all 1 papers on self- and family management program
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“the intervention group demonstrated significantly greater improvements than the control group in exercise tolerance (6MWT: Week 4: MD = 56.29 m, p = .003; Week 8: MD = 99.07 m, 95% CI [62.59, 135.55], p < .001)”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Mahidol University
- Human trial1
Studies in people
1 study gave self- and family management program to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves exercise toleranceMD 99.07 m, 95% CI 62.59 to 135.55 down: Decreases dyspnea severityMD − 29.29, 95% CI − 32.11 to − 26.47 no change: Has no effect on self-management behaviorsMD 3.33, 95% CI − 1.02 to 7.69 | Randomized trial8 weeks | 86 peoplepredominantly male (85.7%)approximately 69 yearsOlder patients with COPD along with their family caregivers | BMC geriatrics, Mar 19, 2026 |
What did studies of self- and family management program find?
4Studies of self- and family management program measured 4 outcomes, among them depression, self-management behaviors and dyspnea severity.
Depression
no changein humans1
1 study
Depression
no changein humans1
Self- and family management program showed no clear effect on depression in humans.
“As shown in Table, no significant group × time interaction effect was observed for depression (F = 0.00, p = 1.00, η2=0.000).”
Human trial8 weeksn = 86
BMC geriatrics
Self- and family management program showed no clear effect on depression in humans (chronic obstructive pulmonary disease) (not statistically significant).
“Between-group differences in self-management behaviors and depression were not statistically significant at any time point.”
Human trialchronic obstructive pulmonary disease8 weeksn = 86
BMC geriatrics
Self-management behaviors
no changein humans1
1 study
Self-management behaviors
no changein humans1
Self- and family management program showed no clear effect on self-management behaviors in humans (MD 3.33, 95% CI − 1.02 to 7.69).
“Self-management scores in the intervention group remained higher but were still not statistically different from the control group (MD 3.33, 95% CI − 1.02 to 7.69, p =.132).”
Human trial8 weeksn = 86
BMC geriatrics
Self- and family management program showed no clear effect on self-management behaviors in humans (chronic obstructive pulmonary disease) (not statistically significant).
“Between-group differences in self-management behaviors and depression were not statistically significant at any time point.”
Human trialchronic obstructive pulmonary disease8 weeksn = 86
BMC geriatrics
Dyspnea severity
downin humans1
1 study
Dyspnea severity
downin humans1
Self- and family management program decreases dyspnea severity in humans (MD − 29.29, 95% CI − 32.11 to − 26.47).
“As shown in Table, dyspnea scores revealed a significant improvement with a substantial group × time interaction effect (F = 205.07, p <.001, η2=0.714), representing the largest effect size among all measured outcomes.”
Human trial8 weeksn = 86
BMC geriatrics
Self- and family management program decreases dyspnea severity in humans (chronic obstructive pulmonary disease) (MD = -29.29, 95% CI [-32.11, -26.47]).
“dyspnea severity (Week 4: MD = − 15.24, p < .001; Week 8: MD = − 29.29, 95% CI [− 32.11, − 26.47], p < .001)”
Human trialchronic obstructive pulmonary disease8 weeksn = 86
BMC geriatrics
Exercise tolerance
upin humans1
1 study
Exercise tolerance
upin humans1
Self- and family management program improves exercise tolerance in humans (MD 99.07 m, 95% CI 62.59 to 135.55).
“As shown in Table, the 6MWT revealed a significant improvement with a substantial group × time interaction effect (F = 83.19, p <.001, η2=0.504), representing the strongest effect size among all measured outcomes.”
Human trial8 weeksn = 86
BMC geriatrics
Self- and family management program improves exercise tolerance in humans (chronic obstructive pulmonary disease) (MD = 99.07 m, 95% CI [62.59, 135.55]).
“the intervention group demonstrated significantly greater improvements than the control group in exercise tolerance (6MWT: Week 4: MD = 56.29 m, p = .003; Week 8: MD = 99.07 m, 95% CI [62.59, 135.55], p < .001)”
Human trialchronic obstructive pulmonary disease8 weeksn = 86
BMC geriatrics